According to the Clinical Practice Guidelines for Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) provided by the KDIGO [26], 37.35%, 44.58%, and 78.31% of the patients showed abnormalities in Ca, P, and PTH levels, respectively. The gene discussed is PTH; the disease is chronic kidney disease.